The Center for Skin Cancer and Melanoma
Our highly skilled practitioners use the latest technology to detect skin cancer. The most common of all cancers, skin cancer accounts for nearly half of all cancer cases in the U.S. More than 3.5 million cases of basal cell and squamous cell skin cancer are diagnosed in this country each year.
The American Cancer Society estimates for melanoma in the U.S. for 2019 are: about 96,480 new melanomas will be diagnosed (about 57,220 in men and 39,260 in women). About 7,230 people are expected to die of melanoma (about 4,740 men and 2,490 women). In recent years, the number of melanoma cases has increased significantly (2013-76,600 versus 2019-96,480).
Melanoma can arise from moles that often have been inconspicuous over years, or more commonly suddenly appear on healthy skin.
Patients at The Center for Skin Cancer and Melanoma often have a personal or family history of melanoma, or have numerous brown or black skin moles.
Our Center uses the DermaGraphix IntelliStudio system, the latest technology for the prevention, early diagnosis and aftercare of skin cancer and/or malignant melanoma. We were the first to utilize this advanced technology.
A pain-free body map session can document the whole skin surface and may produce potentially lifesaving results. The hand-held VEOS DS3 dermatoscope and the VEOS app allow for close up and dermoscopic photos to be tagged to the overview images to localize moles and find them on subsequent visits. These photos provide a side-by-side comparison of baseline and follow-up pictures, the most reliable means of accurately tracking changes over time.
Total body mapping together with digital dermoscopy have become a tool for monitoring high risk patients with a personal or family history of melanoma or worrisome moles. This technology allows us to detect melanoma at its earliest stage. When treated early, melanoma is most manageable.
During the procedure, patients can follow the exam on the screen.
Among the advantages of Total Body Mapping is long-term observation through mole mapping.
- Moles at risk and new moles are detected at an early stage.
- We can see even the slightest changes in structure by comparing moles over time.
- Continuous skin checks help avoid unnecessary excisions (scars).
Patients are seen at the Wheeling Hospital Center for Skin Cancer and Melanoma Monday through Friday from 8:30 a.m. to 5 p.m. The office is located in Tower 1, Suite 101. For more information or to schedule an appointment, call 304-243-3134.